Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation: 22/03/2017, Revision: 38, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 10 September 2026 - 15:22

Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation: 22/03/2017, Revision: 38, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/xeljanz

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters